Stockreport

Gilead: Why The 'Immune System Company' Pivot Is No Longer A Bargain (Downgrade) [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF The HIV franchise remains GILD's core strength, while Trodelvy's first-line approval in mTNBC supports growth. Cell therapy headwinds and GILD reliance on M&A for pip [Read more]